Sylvie Bouvier

Sylvie Bouvier

Auto-generated profile, based on publicly available information

Sylvie Bouvier

UMR1318 INSERM - UM Institut Desbrest d'´Epidémiologie et de Santé Publique (IDESP), University of Montpellier, Montpellier, France; Department of Hematology and Immunology, Nîmes University Hospital, Nîmes, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in Blood
Verified
Journal Article
Closed access
PDF file
SBSylvie Bouvier
Sylvie Bouvier
ÉCÉva Cochery-Nouvellon
Éva Cochery-Nouvellon
GLGéraldine Lavigne-Lissalde
Géraldine Lavigne-Lissalde
ÉMÉrick Mercier
Érick Mercier
TMTess Marchetti
Tess Marchetti
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
Key Points: Among women with pure obstetric APS, late pregnancy complications are more frequent in cases of prior fetal loss. Late pregnancy complications are more frequent among women treated for pure obstetric APS than among nontreated controls.

15 March 2012 in Blood
Verified
Journal Article
Closed access
PDF file
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
SBSylvie Bouvier
Sylvie Bouvier
NMNicolas Molinari
Nicolas Molinari
JGJean-Philippe Galanaud
Jean-Philippe Galanaud
ÉCÉva Cochery-Nouvellon
Éva Cochery-Nouvellon
MDMichel Dauzat
Michel Dauzat
The incidence of thrombosis in the purely obstetric form of antiphospholipid syndrome is uncertain. We performed a 10-year observational study of 1592 nonthrombotic women who had experienced 3 consecutive spontaneous abortions before the 10th week of gestation or 1 fetal death at or beyond the 10th week of gestation. We compared the frequencies of thrombotic events among women positive for antiphospholipid Abs (n = 517), women carrying the F5 6025 or F2 rs1799963 polymorphism (n = 279), and women with negative thrombophilia screening results (n = 796). The annual rates of deep vein thrombosis (1.46%; range, 1.15%-1.82%), pulmonary embolism (0.43%; range, 0.26%-0.66%), superficial vein thrombosis (0.44%; range, 0.28%-0.68%), and cerebrovascular events (0.32%; range, 0.18%-0.53%) were significantly higher in aPLAbs women than in the other groups despite low-dose aspirin primary prophylaxis. Women carrying 1 of the 2 polymorphisms did not experience more thrombotic events than women who screened negative for thrombophilia. Lupus anticoagulant was a risk factor for unprovoked proximal and distal deep and superficial vein thrombosis and women in the upper quartile of lupus anticoagulant activity had the highest risk. Despite data suggesting that aPLAbs may induce pregnancy loss through nonthrombotic mechanisms, women with purely obstetric antiphospholipid syndrome are at risk for thrombotic complications.

5 January 2023 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
FGFlorence Guillotin
Florence Guillotin
MFMathieu Fortier
Mathieu Fortier
MPMarie Portes
Marie Portes
CDChristophe Demattei
Christophe Demattei
EMEve Mousty
Eve Mousty
SBSylvie Bouvier
Sylvie Bouvier
Background: NETosis occurs in the context of infection or inflammation and results in the expulsion of decondensed DNA filaments called NETs (Neutrophil Extracellular Traps) into the extracellular environment. NETosis activates coagulation and contributes to the thrombotic risk of inflammatory diseases. To date, two mechanisms of NETosis have been identified: suicidal NETosis, in which neutrophils die after expelling the filaments; and vital NETosis, in which expulsion appears without altering the membrane. Human pregnancy is associated with a mild pro-inflammatory state, which is increased in the event of complications such as preeclampsia (PE). NETosis has been observed in these situations, but the mechanism of its production has not yet been studied. The aim of our study was to evaluate the balance of vital vs. suicidal NETosis in normal pregnancy and in PE.Patients/Methods: Neutrophils from healthy volunteers were stimulated with plasma from normal pregnancies (n = 13) and from women developing preeclampsia (n = 13). Immunofluorescent labelling was performed to determine the percentages and origin of NETs in both groups. Inhibition with suicidal or vital NETosis inhibitors was also performed to validate our results.Results: We found a significant increase in NETs in women with PE compared to women with normal pregnancies. We showed that vital and non-vital NETosis are present in normal and preeclamptic pregnancies. We demonstrated that the higher proportion of NETs observed in PE was due to non-vital NETosis whose main component is represented by suicidal NETosis.Discussion: These results suggest the important part of non-vital NETosis in the pathophysiology of PE.

1 February 2015 in Thrombosis Research
Verified
Journal Article
Closed access
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
BNBenédicte Nobile
Benédicte Nobile
SBSylvie Bouvier
Sylvie Bouvier

16 January 2014 in Blood
Verified
Journal Article
Closed access
PDF file
SBSylvie Bouvier
Sylvie Bouvier
ÉCÉva Cochery-Nouvellon
Éva Cochery-Nouvellon
GLGéraldine Lavigne-Lissalde
Géraldine Lavigne-Lissalde
ÉMÉrick Mercier
Érick Mercier
PFPascale Fabbro-Peray
Pascale Fabbro-Peray
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
The incidence of pregnancy outcomes in women with constitutive thrombophilia is uncertain. We observed women with no history of thrombotic events (nonthrombotic), who had experienced 3 consecutive spontaneous abortions before the 10th week of gestation or 1 fetal death at or beyond the 10th week of gestation. We compared the frequencies of complications during a new pregnancy attempt among women carrying the F5 rs6025 or F2 rs1799963 polymorphism (n = 279; low-molecular-weight heparin [LMWH] treatment during pregnancy only in case of prior fetal death), and women with negative thrombophilia screening results as control women (n = 796; no treatment). Among women with prior recurrent abortions, thrombophilic women were at increased risk for fetal death. Among women with prior fetal death, thrombophilic women experienced less fetal death recurrences, less preterm births and preeclampsia, and more live births as they were treated with LMWH. In nonthrombotic F5 rs6025 or F2 rs1799963 heterozygous women with prior pregnancy loss, fetal loss may indicate a clinical subgroup in which future therapeutic randomized controlled trials testing the effect of LMWH prophylaxis are required in priority.

1 February 2014 in The American Journal of Pathology
Verified
Journal Article
Open access
MVMagalie Vatin
Magalie Vatin
SBSylvie Bouvier
Sylvie Bouvier
LBLinda Bellazi
Linda Bellazi
XMXavier Montagutełłi
Xavier Montagutełłi
PLPaul Laissue
Paul Laissue
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
Fertility is a quantitative, complex character governed by a considerable number of genes. Despite clinical and scientific advances, several cases of human infertility remain unexplained. In the present study, using a positional cloning approach in a mouse model of interspecific recombinant lines, a candidate gene, ALPP, encoding the placental alkaline phosphatase, was identified as being potentially involved in recurrent spontaneous abortion. We then analyzed patients for detecting putative associations between ALPP polymorphisms, in vitro fertilization failures, and miscarriages. ALPP was sequenced in 100 controls and 100 patients affected by recurrent spontaneous abortion, from the same ethnic background. The frequency of several alleles and allelic combinations were different between recurrent spontaneous abortion and control women. One polymorphism induced a coding substitution (Ile89Leu) that was associated with a decreased risk of abortion and in vitro fertilization failure. Thereafter, the population was increased by the analysis of 92 additional controls and 612 additional patients for the coding polymorphism Ile89Leu. We finally show, by functional analysis, that the 89Leu placental alkaline phosphatase has an enhanced alkaline phosphatase activity. This study suggests that ALPP genotyping could be a strong predictor of implantation success.